Abstract | BACKGROUND: Clinical and virologic consequences of temporary interruption of HIV therapy are incompletely understood. OBJECTIVE: To describe a febrile illness that was consistent with the acute HIV syndrome and occurred after interruption of antiretroviral therapy. DESIGN: Case report. SETTING: University clinic. PATIENT: HIV-infected man. MEASUREMENTS: Plasma viral load, lymphocyte subsets, diagnostic evaluation (including cultures and serologic tests), and analysis of lymph node tissue. RESULTS: The patient began antiretroviral therapy 3 months after initial HIV exposure and had sustained viral suppression, except during a brief scheduled treatment interruption. One hundred sixty-nine days after resuming therapy, the patient discontinued it again immediately following an influenza vaccination. Eleven days later, he presented with a febrile mononucleosis-like syndrome associated with dramatic shifts in plasma HIV RNA level (<50 to >1 000 000 copies/mL) and CD4 cell count (0.743 x 10(9) cells/L to 0.086 x 10(9) cells/L). Evaluation for alternative causes of fever was unrevealing. Symptoms resolved rapidly with resumption of HIV therapy. CONCLUSION: Therapeutic interruption may be associated with profound viral rebound and recurrence of the acute HIV syndrome.
|
Authors | J M Kilby, P A Goepfert, A P Miller, J W Gnann Jr, M Sillers, M S Saag, R P Bucy |
Journal | Annals of internal medicine
(Ann Intern Med)
Vol. 133
Issue 6
Pg. 435-8
(Sep 19 2000)
ISSN: 0003-4819 [Print] United States |
PMID | 10975961
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)
|
Chemical References |
- Anti-HIV Agents
- HIV Protease Inhibitors
- RNA, Viral
- Reverse Transcriptase Inhibitors
- Lamivudine
- Zidovudine
- Indinavir
|
Topics |
- Acute Disease
- Adult
- Anti-HIV Agents
(therapeutic use)
- CD4 Lymphocyte Count
- Chronic Disease
- Disease Progression
- Drug Therapy, Combination
- Fever
(virology)
- HIV
(genetics)
- HIV Infections
(drug therapy, immunology, virology)
- HIV Protease Inhibitors
(therapeutic use)
- Humans
- Indinavir
(therapeutic use)
- Lamivudine
(therapeutic use)
- Male
- RNA, Viral
(blood)
- Recurrence
- Reverse Transcriptase Inhibitors
(therapeutic use)
- Syndrome
- Viral Load
- Zidovudine
(therapeutic use)
|